This site is for US residents only.
We know that living with Familial Chylomicronemia Syndrome (FCS) and beginning a new treatment can be challenging. The Rely On Redemplo® Patient Support Program care team is here to help right from the start. We offer services and resources to aid and guide you throughout your treatment journey.
We’re ready to help you. The Rely On Redemplo Patient Support Program offers a number of support options aimed at helping you at every stage of treatment.
Starter Kit shipped directly to your house when you start your first dose. It includes clear, simple instructions and helpful tools to safely and confidently support your treatment with Redemplo®.
A training video that teaches you the steps to self-inject Redemplo at home using a pre-filled syringe.
View Injection Training VideoA pharmacist who can answer questions that you or your caregiver may have about Redemplo.
REDEMPLO® (plozasiran) is an injectable prescription medicine used together with a low-fat diet to reduce triglycerides (fat in the blood) in adults with a condition that keeps the body from breaking down fats called familial chylomicronemia syndrome (FCS).
Before you start using REDEMPLO, tell your healthcare provider about all your medical conditions, including if you are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. It is not known if REDEMPLO could harm your unborn baby, or if it passes into your breast milk and could harm your breastfeeding baby.
Tell your healthcare provider or pharmacist about any prescription and over-the-counter medicines, vitamins, or herbal supplements you take.
The most common side effects of REDEMPLO include increased blood sugar levels, headache, nausea, and injection site reactions (pain, redness, or swelling).
These are not all the possible side effects of REDEMPLO. Tell your healthcare provider or treatment team if you have any side effect that bothers you or that does not go away.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/safety/medwatch, or call 1-800-FDA-1088.